These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28673316)

  • 1. Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis.
    Bado I; Nikolos F; Rajapaksa G; Wu W; Castaneda J; Krishnamurthy S; Webb P; Gustafsson JÅ; Thomas C
    Breast Cancer Res; 2017 Jul; 19(1):79. PubMed ID: 28673316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphiregulin deletion strongly attenuates the development of estrogen receptor-positive tumors in p53 mutant mice.
    Meier DR; Girtman MA; Lofgren KA; Kenny PA
    Breast Cancer Res Treat; 2020 Feb; 179(3):653-660. PubMed ID: 31838731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.
    Song P; Li Y; Dong Y; Liang Y; Qu H; Qi D; Lu Y; Jin X; Guo Y; Jia Y; Wang X; Xu W; Quan C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):354. PubMed ID: 31412908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O; Lattrich C; Springwald A; Ortmann O
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like breast tumors by restricting luminal progenitor cell expansion.
    Faraldo MM; Romagnoli M; Wallon L; Dubus P; Deugnier MA; Fre S
    Breast Cancer Res; 2024 Jun; 26(1):91. PubMed ID: 38835038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERβ modulates genistein's cisplatin-enhancing activities in breast cancer MDA-MB-231 cells via P53-independent pathway.
    Liu R; Xu X; Liang C; Chen X; Yu X; Zhong H; Xu W; Cheng Y; Wang W; Wu Y; Yu L; Hu X
    Mol Cell Biochem; 2019 Jun; 456(1-2):205-216. PubMed ID: 30737644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
    Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
    J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
    Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM
    PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression.
    Morrison CD; Allington TM; Thompson CL; Gilmore HL; Chang JC; Keri RA; Schiemann WP
    Oncotarget; 2016 Nov; 7(45):72777-72794. PubMed ID: 27626309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function.
    Bado I; Nikolos F; Rajapaksa G; Gustafsson JÅ; Thomas C
    Oncotarget; 2016 Mar; 7(12):13599-611. PubMed ID: 26871946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
    Lo PK; Lee JS; Liang X; Sukumar S
    Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lunatic Fringe and p53 Cooperatively Suppress Mesenchymal Stem-Like Breast Cancer.
    Chung WC; Zhang S; Challagundla L; Zhou Y; Xu K
    Neoplasia; 2017 Nov; 19(11):885-895. PubMed ID: 28938159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.
    Paris O; Ferraro L; Grober OM; Ravo M; De Filippo MR; Giurato G; Nassa G; Tarallo R; Cantarella C; Rizzo F; Di Benedetto A; Mottolese M; Benes V; Ambrosino C; Nola E; Weisz A
    Oncogene; 2012 Sep; 31(38):4196-206. PubMed ID: 22231442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis.
    Fifield BA; Qemo I; Kirou E; Cardiff RD; Porter LA
    Breast Cancer Res; 2019 Dec; 21(1):140. PubMed ID: 31829284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway.
    Bowers LW; Wiese M; Brenner AJ; Rossi EL; Tekmal RR; Hursting SD; deGraffenried LA
    PLoS One; 2015; 10(12):e0145452. PubMed ID: 26709918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.